Pharmacological characterization of cannabinoids in the elevated plus maze.
E. Onaivi, M. Green, B. Martin
Journal of Pharmacology and Experimental Therapeutics June 1, 1990 DOI: 10.1016/s0022-3565(25)13195-9 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal behavioral pharmacology study Peer reviewed |
|---|---|
| Population | Rats and mice |
| Interventions | delta 9-THC delta 9-11-THC 12 beta-NH2-delta 8-THC levonantradol (-)-11-OH-delta 8-THC-DMH (+)-11-OH-delta 8-THC-DMH cannabidiol nabilone diazepam 11-nor-delta 8-THC-9-carboxylic acid abnormal cannabidiol carboline-3-carboxylate |
| Measures | elevated plus maze |
| Key points | Delta 9-THC increased open-arm avoidance in rats and mice, an effect the authors interpret as anxiety-like and about three times stronger in rats. Several related cannabinoids produced similar effects, and the response was enantioselective. Cannabidiol and nabilone instead increased open-arm time, resembling diazepam, and carboline-3-carboxylate or diazepam pretreatment blocked delta 9-THC's effect. |
Abstract
delta 9-Tetrahydrocannabinol (delta 9-THC) induced in both rats and mice an increased aversion to the open arms of the elevated plus maze which was similar to that produced by anxiogenic agents. This effect of delta 9-THC was approximately three times greater in rats than in mice. When the behavioral effects of the cannabinoids were characterized further in the mouse, it was found that delta 9-11-THC, 12 beta-NH2-delta 8-THC, levonantradol and (-)-11-OH-delta 8-THC-DMH produced effects that were similar to those of delta 9-THC. The effect was found to be enantioselective in that (+)-11-OH-delta 8-THC-DMH was inactive even at a dose 200 times greater than an active dose of (-)-11-OH-delta 8-THC-DMH. In contrast to the effects of delta 9-THC, mice treated with cannabidiol and nabilone spent a greater amount of time in the open arm of the maze, an effect similar to that produced by diazepam, the reference anxiolytic agent. In this test situation, 11-nor-delta 8-THC-9-carboxylic acid and abnormal cannabidiol did not alter the behavior of the animals at doses up to 20 and 100 mg/kg, respectively. Pretreatment with either the bidirectional inverse agonist carboline-3-carboxylate or diazepam (at doses that did not modify normal behavior on the elevated plus maze) blocked the effect of delta 9-THC.(ABSTRACT TRUNCATED AT 250 WORDS)
Citations in the library
Cited by 36
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug Brazilian Journal of Medical and Biological Research April 1, 2006
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers Current Pharmaceutical Design September 12, 2012
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects Frontiers in Behavioral Neuroscience 2011
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties Journal of Translational Medicine October 2, 2020
- Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors Neuropsychopharmacology November 27, 2018
and 31 more in the library